Marija Cauchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marija Cauchi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Angela Andrews
Pharmacy Neurosciences Directorate, University Hospital of Wales, Cardiff, UK
1 shared publicationBruno Gran
Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK
1 shared publication- Emma Clare Tallantyre
Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK
1 shared publication Harriet Ball
Population Health Sciences, Bristol Medical School, Bristol, UK
1 shared publication- Helen L. Ford
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom LS1 3Ex
1 shared publication - Klaus Schmierer
Queen Mary University of London
1 shared publication
Latest Publications
- 21 July 2022
- Published by BMJ in Practical Neurology
- Vol. 22 (5) , 344-357
Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receiving disease-modifying therapies. This article explores the risk of infection in people with MS and provides guidance—developed by Delphi consensus by specialists involved in their management—on how to screen for, prevent and manage infection in this population.
- 21 July 2022
- Published by BMJ in Practical Neurology
- Vol. 22 (5) , 344-357
Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receiving disease-modifying therapies. This article explores the risk of infection in people with MS and provides guidance—developed by Delphi consensus by specialists involved in their management—on how to screen for, prevent and manage infection in this population.
- Open Access
- 16 August 2021
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (1) , 493-503
Interpretation of vaccine associated neurological adverse events: a methodological and historical review
As a result of significant recent scientific investment, the range of vaccines available for COVID-19 prevention continues to expand and uptake is increasing globally. Although initial trial safety data have been generally reassuring, a number of adverse events, including vaccine induced thrombosis and thrombocytopenia (VITT), have come to light which have the potential to undermine the success of the vaccination program. However, it can be difficult to interpret available data and put these into context and to communicate this effectively. In this review, we discuss contemporary methodologies employed to investigate possible associations between vaccination and adverse neurological outcomes and why determining causality can be challenging. We demonstrate these issues by discussing relevant historical exemplars and explore the relevance for the current pandemic and vaccination program. We also discuss challenges in understanding and communicating such risks to clinicians and the general population within the context of the ‘infodemic’ facilitated by the Internet and other media.
- 16 August 2021
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (1) , 493-503
Open AccessInterpretation of vaccine associated neurological adverse events: a methodological and historical review
As a result of significant recent scientific investment, the range of vaccines available for COVID-19 prevention continues to expand and uptake is increasing globally. Although initial trial safety data have been generally reassuring, a number of adverse events, including vaccine induced thrombosis and thrombocytopenia (VITT), have come to light which have the potential to undermine the success of the vaccination program. However, it can be difficult to interpret available data and put these into context and to communicate this effectively. In this review, we discuss contemporary methodologies employed to investigate possible associations between vaccination and adverse neurological outcomes and why determining causality can be challenging. We demonstrate these issues by discussing relevant historical exemplars and explore the relevance for the current pandemic and vaccination program. We also discuss challenges in understanding and communicating such risks to clinicians and the general population within the context of the ‘infodemic’ facilitated by the Internet and other media.